Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Denmark
Clinical trial register · Denmark

Clinical Trials in Denmark

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2472 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:19 UTC
2472
Studies in scope
all four open statuses
1403
Recruiting now
open to new participants
448
Lead sponsors
across recruiting studies
Top sites
Herlev 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Copenhagen University Hospital, Rigshospitalet192 University of Aarhus190 Odense University Hospital101 Aarhus University Hospital75 AstraZeneca58 Merck Sharp & Dohme LLC50 University of Copenhagen47 Hoffmann-La Roche45 University of Southern Denmark41 Zealand University Hospital40 Aalborg University Hospital38 Novartis Pharmaceuticals36 Janssen Research & Development, LLC33 Herlev and Gentofte Hospital33 Eli Lilly and Company32 Novo Nordisk A/S32 Bispebjerg Hospital28 AbbVie25 Aalborg University25 Sanofi25 Steno Diabetes Center Copenhagen24 Nordsjaellands Hospital21 Hvidovre University Hospital21 Bristol-Myers Squibb20 Copenhagen University Hospital, Hvidovre19 Vejle Hospital18 Herlev Hospital18 Amgen18 Pfizer16 Bayer16 University Hospital Bispebjerg and Frederiksberg15 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital15 Gødstrup Hospital15 Boehringer Ingelheim14 Esbjerg Hospital - University Hospital of Southern Denmark13 University Hospital, Gentofte, Copenhagen13 Genmab13 GlaxoSmithKline12 Abbott Medical Devices11 Incyte Corporation11 Tor Biering-Sørensen11 Copenhagen University Hospital at Herlev10 Danish Headache Center10 Takeda9 Danish Research Centre for Magnetic Resonance9 argenx9 European Organisation for Research and Treatment of Cancer - EORTC8 Stichting Hemato-Oncologie voor Volwassenen Nederland8 Zimmer Biomet8 Celgene7 Aarhus University Hospital Skejby7 Center for Clinical Research and Prevention7 Morten Hostrup, PhD7 University Hospital Schleswig-Holstein6 Martin Blomberg Jensen6 Copenhagen Studies on Asthma in Childhood6 Princess Maxima Center for Pediatric Oncology6 CSL Behring6 Medtronic Cardiovascular6 Gustave Roussy, Cancer Campus, Grand Paris6 Alexion Pharmaceuticals, Inc.5 Daiichi Sankyo5 Copenhagen Respiratory Research5 Inge Marie Svane5 Alnylam Pharmaceuticals5 Population Health Research Institute5 Vastra Gotaland Region5 Central Jutland Regional Hospital5 Regionshospital Nordjylland5 Glostrup University Hospital, Copenhagen5 Inna Chen, MD5 Jørgen Bjerggaard Jensen4 Prehospital Center, Region Zealand4 Danish Breast Cancer Cooperative Group4 W.L.Gore & Associates4 Ove Andersen4 Kolding Sygehus4 Genentech, Inc.4 Oslo University Hospital4 Slagelse Hospital4 Boston Scientific Corporation4 Astellas Pharma Global Development, Inc.4 Carsten Dirksen4 Susanne Dam Nielsen, MD, DMSc4 Tesaro, Inc.4 Medtronic4 Agios Pharmaceuticals, Inc.4 Merete Haedersdal3 Loxo Oncology, Inc.3 Spine Centre of Southern Denmark3 Amsterdam UMC, location VUmc3 Lone Baandrup3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3 Philips Clinical & Medical Affairs Global3 Coloplast A/S3 Universitätsklinikum Hamburg-Eppendorf3 Danish Dementia Research Centre3 Dianthus Therapeutics3 Genzyme, a Sanofi Company3 Caroline Michaela Kistorp3 Copenhagen Academy for Medical Education and Simulation3 Central Denmark Region3 Naestved Hospital3 Laura Ozer Kettner3 The Danish Center for Expertise in Rheumatology3 Region Zealand3 Amager Hospital3 Nils Hoyer3 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company3 Blueprint Medicines Corporation3 St. Olavs Hospital3 Tejs Ehlers Klug3 University Medical Center Groningen3 Anders Fink-Jensen, MD, DMSci3 German CLL Study Group3 Region of Southern Denmark3 University College Copenhagen3 Bjorn H. Ebdrup3 UMC Utrecht3 Charite University, Berlin, Germany3 BeOne Medicines3 Biosense Webster, Inc.3 Thomas Engstrom3 Calcilytix Therapeutics, Inc., a BridgeBio company2 Seagen, a wholly owned subsidiary of Pfizer2 Andreas Munk Petersen2 Acerta Pharma BV2 Medical University of Vienna2 Eikon Therapeutics2 Institut de Recherches Internationales Servier2 Regionshospitalet Silkeborg2 Materialise2 Mario Negri Institute for Pharmacological Research2 Region Skane2 Institut National de la Santé Et de la Recherche Médicale, France2 Kardigan, Inc.2 Avidity Biosciences, Inc.2 Christian Hassager2 InnoCon Medical2 Day One Biopharmaceuticals, Inc.2 SynAct Pharma Aps2 Turning Point Therapeutics, Inc.2 Insmed Incorporated2 Karyopharm Therapeutics Inc2 CoreAalst BV2 Psychiatric Research Unit, Region Zealand, Denmark2 Kresten Krarup Keller2 Ferring Pharmaceuticals2 Ole Lander Svendsen2 Erasmus Medical Center2 Haukeland University Hospital2 Karen-Lise Garm Spindler2 Leiden University Medical Center2 Mats Heyman2 Claus Bogh Juhl2 University Hospital Muenster2 Marius Henriksen2 University of Calgary2 Ditte Hansen2 Regeneron Pharmaceuticals2 VectivBio AG2 Merz Therapeutics GmbH2 Professor Klaus Bønnelykke2 Ad scientiam2 Pharming Technologies B.V.2 Vibeke Backer2 Jimmi Nielsen2 Klavs Würgler Hansen2 Lars Wiuff Andersen2 Gitte Fredberg Persson MD PhD2 Niels Fristrup2 Peter Humaidan2 Mette Hansen2 Cytokinetics2 University College of Northern Denmark2 University Hospital, Antwerp2 Asger Lund, MD2 University Hospital of North Norway2 Ole Köhler-Forsberg2 Nordic Society of Gynaecological Oncology - Clinical Trials Unit2 Ole De Backer2 Soren Overgaard2 Ionis Pharmaceuticals, Inc.2 Nicolai Jacob Wewer Albrechtsen2 ML Bio Solutions, Inc.2 Ethicon, Inc.2 Immunovant Sciences GmbH2 Istituto Giannina Gaslini2 Northern Orthopaedic Division, Denmark2 Nordic Lymphoma Group2 King's College London2 Kirsten Grønbæk2 Gitte Moos Knudsen2 Radiometer Medical ApS2 Lupin Ltd.2 Uppsala University2 Servier Bio-Innovation LLC2 Zenas BioPharma (USA), LLC2 Debiopharm International SA2 Region Örebro County2 Anteris Technologies Ltd.2 Eidos Therapeutics, a BridgeBio company2 Ipsen2 University of Birmingham2 Stemline Therapeutics, Inc.2 Bo Feldt-Rasmussen2 BioNTech SE2 Revolution Medicines, Inc.2 Vertex Pharmaceuticals Incorporated2 Biogen2 Holbaek Sygehus2 Claus Lindbjerg Andersen2 Klaus Martiny2 Tobias Todsen2 IO Biotech2 Rune Skovgaard Rasmussen2 Leif Thuesen2 UCB Biopharma SRL2 Morten Ladekarl2 Ascendis Pharma A/S2 Helena DOMINGUEZ2 Norwegian University of Science and Technology2 Sahlgrenska University Hospital2 United Therapeutics2 Steen Hvitfeldt Poulsen2 European Myeloma Network B.V.2 Eske Kvanner Aasvang2 Peter Rossing2 Tampere University Hospital2 BioInvent International AB2 Celldex Therapeutics2 ViiV Healthcare2 Ulrik Lassen2 Grifols Therapeutics LLC2 Marianne Andersen2 Mirati Therapeutics Inc.2 Ascendis Pharma Growth Disorders A/S2 Lone Skov2 Biohaven Therapeutics Ltd.2 Barbara Malene Fischer2 Karolinska Institutet2 Evald Hoej Christiansen2 PedAL BCU, LLC1 Aleksander Krag1 Geron Corporation1 pharmaand GmbH1 Verastem, Inc.1 Ismail Gögenur1 Celcuity Inc1 The University of Queensland1 Rasmus Bo Hasselbalch1 Gossamer Bio USA, Inc.1 Javier P. Gisbert1 Heart Care Foundation1 Anne Estrup Olesen1 Klaus Fuglsang Kofoed1 Thomas Benfield1 Jakob Stokholm1 Bo Biering-Soerensen1 Jesper Kjaergaard1 Medtronic - MITG1 Ribocure Pharmaceuticals AB1 Emergency Medical Services, Capital Region, Denmark1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Lund University Hospital1 HerAccess ApS1 University of Minnesota1 Region MidtJylland Denmark1 SAb Biotherapeutics, Inc.1 Change Accelerator in Respiratory Care1 Helsinki University Central Hospital1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Angitia Incorporated Limited1 Protara Therapeutics1 Anders Odgaard1 Anne Katrine Pagsberg1 KeyBioscience AG1 Danish Lung Cancer Group1 Vedanta Biosciences, Inc.1 Christoffer Johansen1 COMPASS Pathways1 Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Janssen Pharmaceutica N.V., Belgium1 Åslaug Helland1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 RhoVac APS1 Gilead Sciences1 Morten H. Bestle1 Alumis Inc1 oasicare ApS1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Medtronic Neurovascular Clinical Affairs1 University of Cologne1 Per Løgstrup Poulsen1 St. Antonius Hospital1 Y-mAbs Therapeutics1 Danish Study Group1 Bambino Gesù Hospital and Research Institute1 Curasight1 The Leeds Teaching Hospitals NHS Trust1 Actelion1 Olav Schjørring1 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1 VZW Cardiovascular Research Center Aalst1 Harmony Biosciences Management, Inc.1 Danish Multiple Sclerosis Hospitals1 Sofie Folke1 Dimerix Bioscience Pty Ltd1 Longboard Pharmaceuticals1 RECORDATI GROUP1 Research Unit for General Practice in Aalborg1 Contura1 Kyowa Kirin Pharmaceutical Development Ltd1 Ashkan Eftekhari1 Lise Aksglæde1 Pia Jeppesen1 Jesper Frank Christensen, PhD1 Philipp Dutkowski1 Noema Pharma AG1 Nobel Biocare1 Julie Gehl1 University of Pittsburgh1 Nicholas Carlson1 Optheras AS1 Anders Perner1 Malmö University1 Alimentiv Inc.1 Andreas Sjøholm-Christensen1 Ulrikka Nygaard1 Morten Steen Kvistholm Jensen1 Jesper James Linde1 Tine Gregersen, MD1 Anne Juul Wikkelsø1 Invero Pharma, Inc.1 Maria Lendorf1 PedNet Haemophilia Research Foundation1 Andreas Rosén Rasmussen1 SymBio Pharmaceuticals1 Maja Thiele1 Dyne Therapeutics1 Victoria Rosberg1 Calluna Pharma AS1 Peter Martin Hansen1 Carsten Bogh Juhl1 Inotrem1 Universitaire Ziekenhuizen KU Leuven1 Viatris Innovation GmbH1 Radboud University Medical Center1 Galderma R&D1 Chiesi Pharma AB, Nordic1 Annexon, Inc.1 Nedim Tojaga1 IRCCS San Raffaele1 Regional Hospital West Jutland1 Eclipse Medical Ltd.1 MeiraGTx Ocular UK Ltd1 Jon Unosson1 Janssen-Cilag International NV1 Mads Ryo Jochumsen1 Christian Juhl Terkelsen1 GLSMED Learning Health S.A.1 Thomas Aagaard Rasmussen1 The Netherlands Cancer Institute1 Peter Gaarsdal Uhrbrand1 Brigham and Women's Hospital1 Kirstine Kirkegaard1 Johannes Grand1 H. Lundbeck A/S1 The POLG Foundation1 Akero Therapeutics, Inc1 Nuvalent Inc.1 Molecure S.A.1 Sahajanand Medical Technologies Limited1 Arrowhead Pharmaceuticals1 Jakob Stenman1 Acesion Pharma1 Cystotech1 Urovant Sciences GmbH1 Memorial Sloan Kettering Cancer Center1 Pär Johansson1 Danish Gynecological Cancer Group1 Rikke Sorensen1 Insel Gruppe AG, University Hospital Bern1 Theravance Biopharma1 University of Thessaly1 Josefine Gradman1 Jens D Hove, MD,PHD1 Edwards Lifesciences1 Georgios Tsikandylakis, MD PhD1 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1 Daphne Kos1 Horsens Hospital1 Xentria, Inc.1 OncoZenge AB1 Renaissance Pharma Ltd.1 Jakob Kristian Jakobsen1 St. Anna Kinderkrebsforschung1 Ann-Sofie Backman1 Anna Martling1 Region Västerbotten1 University of Oxford1 Parker Research Institute1 Thomas Helleday Foundation1 Anders Jørgensen1 Cogent Biosciences, Inc.1 MonTa Biosciences ApS1 Thomas Damgaard Sandahl1 University College, London1 Defactum, Central Denmark Region1 Immunocore Ltd1 Anocca AB1 Diagram B.V.1 Rezolute1 Contineum Therapeutics1 Ina Olmer Specht1 Hanna Jangö1 Olfred Hansen1 Matias Vested1 Kristian Kjær Petersen1 InSightec1 Khondrion BV1 Centre Hospitalier Universitaire Vaudois1 Lars Peter Riber1 Associazione Italiana Ematologia Oncologia Pediatrica1 Sanofi Pasteur, a Sanofi Company1 Chronic Obstructive Pulmonary Disease Trial Network, Denmark1 Medical University of Graz1 Cyprus Institute of Neurology and Genetics1 Henrik Bo Wiberg Larsson1 University College Absalon1 Cook Research Incorporated1 VIVE - The Danish Center for Social Science Research1 Arctic Therapeutics1 Vividion Therapeutics, Inc.1 Kartos Therapeutics, Inc.1 Christian Grønhøj Larsen1 Teva Branded Pharmaceutical Products R&D LLC1 Almirall, S.A.1 Johanne Smith-Nielsen1 Arvinas Inc.1 Nina Kimer1 Bioventus LLC1 Guri Hagberg1 Ultragenyx Pharmaceutical Inc1 Britannia Pharmaceuticals Ltd.1 Laboratoires Thea1 Intellia Therapeutics1 EuroBloodNet Association1 Stereotaxis1 Zealand Pharma1 Abdirahman Hassan Omar1 Axel Brandes1 Ulla Feldt-Rasmussen1 Biosensors Europe SA1 Vico Therapeutics B. V.1 Lars Rejnmark1 Signe Torekov1 Relay Therapeutics, Inc.1 Christina Kruuse1 Arash Afshari1 MipSalus Aps1 Thomas Decker Christensen1 Intuitive Surgical1 Atamyo Therapeutics1 Thomas Lund1 Henning Bliddal1 Phillip Freeman1 Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 Jeppe Lange1 Tina Vilsbøll1 Kristine Loessl1 VDyne, Inc.1 Pharmacosmos A/S1 Janssen-Cilag Ltd.1 Jens Rikardt Andersen1 AriBio Co., Ltd.1 Indiana University1 AO Innovation Translation Center1 Ditte Krag-Hansen1 Erling Oma1 Ellen Margrethe Hauge1 BACKBONE1 AB Science1 Universidad Complutense de Madrid1 Ida Bruun Kristensen1 Jacob Bodilsen1 NHS Greater Glasgow and Clyde1 IDEAYA Biosciences1 University Hospital, Ghent1 Bolt Medical1 Sitryx Therapeutics Ltd1 Anne Louise Tølbøll Sørensen1 Kira Bloomquist1 Michelle Baczynski1 Stichting European Myeloma Network1 SecuraBio1 Lolland Community, Denmark1 CDR-Life AG1 Christian von Buchwald1 Bettina Eiger1 Micro Interventional Devices1 Sven Löffeler1 NewAmsterdam Pharma1 Ulla Kampmann Opstrup1 EyeBiotech Ltd.1 Marie Luise Bisgaard, MD1 Iperboreal Pharma Srl1 Line Marker1 Ole Frobert, MD, PhD1 Patrick Schjelderup1 Immunome, Inc.1 Eisai Inc.1 Centre Leon Berard1 Isabelle Opitz, Professor, MD1 Cancer Trials Ireland1 Nowwell AS1 Montefiore Medical Center1 Scandinavian Critical Care Trials Group1 Erasme University Hospital1 Ludwig-Maximilians - University of Munich1 Kimie Bols Østergaard1 Michael Mæng1 Lars Vedel Kessing1 University Hospital, Geneva1 Partner Therapeutics, Inc.1 Hanmi Pharmaceutical Company Limited1 ETOP IBCSG Partners Foundation1 Frederiksberg University Hospital1 Enlivex Therapeutics Ltd.1 Jacob Christiansen Gandløse1 Amicus Therapeutics1 Olof Akre1 Per Ivarsen1 Annemette Lokkegaard1 Brigitta Rasmussen Villumsen1 St George's, University of London1 Henrik Nielsen1 Minervax ApS1 Vitestro B.V.1 Julie Midtgaard1 Mikkel Herly1 Orion Corporation, Orion Pharma1 Camilla Balle1 Bo Gregers Winkel1 European Society of Cardiology1 CHDI Foundation, Inc.1 Spark Therapeutics, Inc.1 Copenhagen Trial Unit, Center for Clinical Intervention Research1 AquaTerapi1 University of Rochester1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Nikolai Albert1 Medtronic MiniMed, Inc.1 Michael Bau Mortensen1 Malene Kjær Bruun1 Imperial College London1 Roche Diagnostics GmbH1 Rapamycin Holdings Inc.1 Ole Schmeltz Søgaard1 Peter Busch Østergren1 AgNovos Healthcare, LLC1 North Estonia Medical Centre1 Children's Fractures Interest Group, Denmark1 Shanghai MicroPort Medical (Group) Co., Ltd.1 Claus Kjærgaard1 Edgewise Therapeutics, Inc.1 Henrik Wiggers1 Xencor, Inc.1 ORNND - Operating Room Nurse Network Denmark1 Pomeranian Medical University Szczecin1 Fondation Hôpital Saint-Joseph1 International CTEPH Association1 Lars Hvid1 Lea Nørgaard Sørensen1 Occlutech International AB1 Aragon Pharmaceuticals, Inc.1 EBR Systems, Inc.1 TILT Biotherapeutics Ltd.1 Alentis Therapeutics AG1 Varian, a Siemens Healthineers Company1 Poitiers University Hospital1 Shionogi1 Henry Smith1 Hamilton Health Sciences Corporation1 Theis S. Itenov1 Deciphera Pharmaceuticals, LLC1 River 3 Renal Corp.1 Marianne Christina Klose1 University of L'Aquila1 AGO Study Group1 Beyond Batten Disease Foundation1 Montreal Heart Institute1 Louise Møldrup Nielsen1 Catharina Ziekenhuis Eindhoven1 MedImmune LLC1 Jazz Pharmaceuticals1 Christian Liebst Frisk Toft1 Institut Investigacio Sanitaria Pere Virgili1 Vibe G Frøkjær, MD, PhD1 CarThera1 srdpiers1 University of Massachusetts, Worcester1 The European Forum for Research and Education in Allergy and Airway Diseases1 UNEEG Medical A/S1 Duke University1 Pulmonx Corporation1 Fundació d'investigació Sanitària de les Illes Balears1 Soren Schou Olesen1 University of Milano Bicocca1 Alliance for Clinical Trials in Oncology1 Vivet Therapeutics SAS1 Claus Anders Bertelsen, PhD, MD1 Christian Mølgaard1 Christiane Marie Bourgin Folke Gam1 Frank G. Holz1 EMD Serono Research & Development Institute, Inc.1 NMD Pharma A/S1 Zimmer, GmbH1 University Hospital, Gasthuisberg1 Niels Junker1 Ryme Medical, Inc.1 Technical University of Denmark1 Weill Medical College of Cornell University1 Nessn Azawi1 Juan Luis Vásquez1 Henning Bundgaard1 Kristian Karstoft1 Acacia Pharma Ltd1 Clear sponsor filter
Site location
Herlev1
All 1 locations
Target enrolment
to

Trials in this register

1 of 2472 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT06276491Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor
Xencor, Inc.
Phase 1
282
Herlev
2024-04-04
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-denmark

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,472 studies in total at the last sync on 18 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Denmark?

1 of the 1 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 1 studies
PhaseStudiesRecruitingShare
Phase 111100%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Xencor, Inc.11

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Ovarian Cancer (1) Endometrial Cancer (1) Germ Cell Tumor (1) Testicular Germ Cell Tumor (1)
→

Browse trials by site location

Herlev (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.